New FDA Approved Treatment For MS Is Being Called A ‘Game Changer’
Multiple sclerosis affects about 400,000 people in the U.S. causing numbness, vision problems, pain and mobility issues.
This new MS treatment comes with a hefty price – $65,000 a year. It will be on the market in the next two weeks.
Mike Miller was diagnosed with multiple sclerosis almost 10 years ago. It started with changes in his vision.
“It took a few years, and I went numb from the waist down,” said Miller.
He is one of the first patients in the country to receive the new FDA approved drug called Ocrevus. The drug treats relapsing MS, which is the most common form and also primary progressive MS, a severe form of the disease. This is first drug ever approved for that.